(2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane

We are (2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane CAS:98737-29-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  (2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane
CAS.NO: 98737-29-2
Synonyms:
(2S,3S)-N-t-Boc-3-amino-1,2-epoxy-4-phenylbutane

Molecular Formula:C15H21NO3
Molecular Weight:263.33200

Physical and Chemical Properties:
Density: 1.118g / cm3
Boiling point: 398.837ºC at 760 mmHg
Melting point: 125-127ºC
Flash point: 195.01ºC
Refractive index: 1.533

Specification:
Appearance:white crystalline powder
Purity:≥98%
Moisture : ≤0.2%
Enantiomers : ≤0.2%
Diastereomers : ≤0.2%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Darunavir ethanolate
 CAS:635728-49-3
Intermediates of Darunavir CAS:206361-99-1
Intermediates of Atazanavir CAS:198904-31-3
Intermediates of Atazanavir sulfate  CAS:229975-97-7

Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.2,4-Dichlorobenzyl chloride At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.534-03-2 At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.3350-78-5 At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities.